drugset / Trial / NCT01633944

Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Naive Subjects

NCT01633944

Phase 3 Completed 752 enrolled BioDelivery Sciences International
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if buprenorphine hydrochloride (HCl) buccal film is effective in treating opioid-naive subjects, with moderate to severe chronic low back pain (CLBP), who require continuous around-the-clock (ATC) pain relief for an extended period of time.

Timeline

Start
2012-08
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified 75 ug Other
Subject Buprenorphine Other / unclassified 600 ug Other

Indications

No indication recorded.